Optimi Health

06/08/2022

Optimi Health is pleased to announce that it has entered into an exploratory supply agreement with ATMA Journey Centers, a privately held facilitator of psilocybin-assisted therapy and practitioner training services for palliative care and mental health conditions based in Calgary, Alberta.

The Company has finalized an agreement which will supply psilocybin products to ATMA for future therapist initiatives and supply requirements.

“Few organizations have made as significant a contribution in recent years to the evolving regulatory conversation around psilocybin-assisted therapy as ATMA Journey Centers,” said Bill Ciprick, CEO of Optimi Health. “Optimi is deeply gratified to be able to provide them with this test supply of natural psilocybin in order to facilitate research that may lead to better mental health services for healthcare workers while testing the potential to expand the scale of available psilocybin therapies.”

Full press release here: http://ow.ly/tovc50JsGGP

05/30/2022

In case you missed it, our very own Todd Henderson was interviewed by CBC News about the grand opening of our 20,000 square foot facility in Princeton, British Columbia.

"[It's] a phenomenal scale ... There is nobody else in the world doing what [we're] doing here right now..."

Full article here:

B.C.-based company Optimi Health has harvested its first cultivation of psilocybin mushrooms at its Health Canada licensed facilities in Princeton, B.C., positioning itself as a major player in the burgeoning psychedelic sector.

05/25/2022

Optimi Health is pleased to announce an historic milestone on the Company’s road to commercialization with the successful completion of its first batches of psilocybin and functional mushrooms.

Read the full press release: http://ow.ly/wuky50JhXrG

05/17/2022

Optimi Health is pleased to announce that it has completed the acquisition of a diverse catalog of psilocybin and functional mushroom strains intended for cultivation in its 20,000 square foot, EU-GMP compliant facility in Princeton, British Columbia.

The Company’s acquisition includes 24 psychedelic and nine functional strains, giving it one of the largest genetic banks in the sector. Formulated psychedelic strains will be made available to licensed researchers, Canada’s Special Access Program (SAP), as well as being utilized for on-site research in Optimi’s recently expanded analytical laboratory, while the functional strains will be optimized for the Company’s growing whole body, natural supplement brand, Optimi Life.

Read the full press release at the Financial Post: http://ow.ly/kPNe50Ja6b0

05/11/2022

Big News!

Optimi Health is pleased to announce that it has completed a planned expansion of the on-site analytical laboratory at its Princeton, British Columbia facility.

The on-site lab is purpose-built inside one of Optimi’s EU-GMP capable 10,000 square foot, state-of-the-art indoor growing facilities dedicated to the cultivation of safe, high-quality psychedelic and functional mushrooms. Optimi Chief Science Officer Justin Kirkland will oversee the Company’s analytical operations.

Read the complete press release here: http://ow.ly/WBoh50J5jRc

05/10/2022

The Optimi leadership team is looking forward to taking part in this year's Catalyst Presents. Join us to help guide Canada's psychedelic journey.

This 3rd annual Catalyst Summit will take place at Queen's University in Kingston, Ontario from May 20-22.

Optimi CEO Bill Ciprick will speak at the Building Canada's Psychedelic Supply panel, from 2:30pm - 3:30pm EST on Saturday, May 21.

Optimi Founder & Director Dane Stevens will speak at the Raising Capital & Understanding the Investor From Within panel from 1:15pm - 2:30pm EST on Friday, May 20, AND the Business of Psychedelics: What Happens After Regulation panel from 3:30 pm - 4:30 pm EST on Saturday, May 21.

Finally, Optimi Chief Science Officer Justin Kirkland will speak at the Landmark Trials Looking Forward panel from 9:00 am - 10:00 am EST on Saturday, May 21.

Complete conference details and tickets are available here: http://ow.ly/QE1V50J4btz

05/04/2022

Big News!

Optimi Health Corp. is pleased to announce that a requested Amendment to its Controlled Substances Dealer’s Licence has been granted by Health Canada, enabling it to further expand the capacity to produce natural, GMP psilocybin at its Princeton, British Columbia facility, as well as introducing a provision allowing the Company to extract psilocin for use in clinical trials.

You can find the full press release on Investing News Network: http://ow.ly/CBaA50IZcgr

05/02/2022

Want to know more about Optimi? Ask us anything.

Starting tomorrow, Bill Ciprick will be taking your questions on r/shroomstocks, the number one psychedelic investment subreddit. Join 50,000+ Redditors to learn about our commitment to life changing medicine, supplied by nature. AMA ends May 17.

Explore shroomstocks: http://ow.ly/6vSQ50IWWWF

04/28/2022

Picked up by the Financial Post.

"Optimi Health Corp. is pleased to announce that it will be inaugurating its recently completed psilocybin cultivation facility with a grand opening event and reception for members of the media, investors and other stakeholders relevant to the Company’s developing position as a leading supplier in the field of psychedelic and functional mushrooms on Friday, May 27th, 2022."

Full release here:

Company will host in-person and virtual tours for media, investors, and residents on May 27, 2022.

04/25/2022

Big news!

Optimi Health will be streaming the grand opening of our Princeton B.C. facility on Friday, May 27th, and we’ve reached out to the incomparable Amanda Siebert to act as our Master of Ceremonies.

Author and Journalist Amanda Siebert has covered the for publications such as Forbes and The Dales Report. We’re proud to have her as part of our team for this one-of-a-kind event.

More details here: http://ow.ly/Iwk150IRHIf

04/22/2022

Bill Ciprick, CEO, and Dane Stevens, CMO, of Optimi Health are hosting a day of presentations for investors, brokers, funds, bankers & analysts on Thursday, April 28.

These live presentations will last approximately 15-20 minutes and then transition into an optional interactive Q & A session.

Join us for lunch or dinner at 12pm ET/PT or 5pm ET/PT.

You can find more information here: http://ow.ly/rUxG50IQoMS

04/20/2022

Optimi is forming the backbone of an evolving treatment ecosystem by ensuring a safe supply of natural mushrooms.

We're here to advance psychedelic science through the use of our GMP psilocybin in clinical trials AND functional healing through our Optimi Life line of mushroom formulations.